Search results

Drug-Abuse Treatment Outcomes Study (DATOS) is a prospective study designed to determine the outcomes of adult drug abuse treatment delivered in typical, stable, community-based programs and to provide comprehensive information on continuing and new questions about the effectiveness of drug abuse treatment for adults currently available in a variety of publicly funded and private programs. The study examined the role of treatment outcomes and program type, client characteristics (including dependence, treatment history, and physical and mental health comorbidities), treatment received (e.g., length and intensity of services provided), therapeutic approaches, provision of aftercare, and research on the components of effective treatment, including factors that engage and retain clients in programs. Four types of programs were included: outpatient methadone (OPM), short-term inpatient (STI), long-term residential (LTR), and outpatient drug-free (ODF). Respondents were sampled from among adults admitted to drug abuse treatment programs in 11 representative U.S. cities during 1991-1993.

Clients entering treatment completed two comprehensive intake interviews (Intake 1 and Intake 2), approximately one week apart. This information is provided in Parts 1 and 2 of the data collection. These interviews were designed to obtain baseline data on drug use and other behaviors, as well as information on background and demographic characteristics, patterns of dependence, living situation and child custody status, education and training, income and expenditures, and HIV risk behaviors, along with assessments of dependence, mental health, physical health, and social functioning. Data on criminal justice status and criminal behavior are reported in Part 5, Illegal Activities Data, and are drawn from the Intake 1 interview. Data reflecting during-treatment progress, including service delivery and client satisfaction, were collected in the one-, three-, and six-month in-treatment interviews (Parts 3, 4, and 8). The 12-Month Post-Treatment Follow-Up Interview (Part 6) replicated many of the intake questions and focused on key behaviors in the year following treatment. Part 7 includes variables for time in treatment and interview availability indicators. The 12-Month Follow-Up Urine Result data (Part 9) provide the results from urine sample tests that were given to a sample of subjects at the time of the 12-Month Follow-Up Interview. Urine specimens were tested for eight categories of drugs (amphetamines, barbiturates, benzodiazepines, cannabinoids, cocaine metabolite, methaqualone, opiates, and phencyclidine). The drugs covered in the study were alcohol, tobacco, marijuana (hashish, THC), hallucinogens or psychedelics such as LSD, mescaline, and PCP, cocaine (including crack), heroin, narcotics or opiates such as morphine, codeine, Demerol, Dilaudid, and Talwin, downers or depressants such as sedatives, barbiturates, and tranquilizers, amphetamines or other stimulants such as speed or diet pills, and other drugs. Part 10 contains data for 1393 clients who were interviewed 5 years post treatment. This part contains many of the same types of questions asked during previous interviews.

This study tested a comprehensive model for couples from at-risk backgrounds on the basis of a dynamic developmental systems approach and stress and support processes to examine the risk and protective impacts of romantic relationships on health in adulthood. It was posited that both general and specific developmental and relationship risks have significant implications for health outcomes in mid-adulthood. In addition, the course of intimate partner violence in early mid-adulthood was examined.

The original Oregon Youth Study (OYS) began in 1983. The goal was to examine the etiology of antisocial behaviors in boys, with a view to designing preventive interventions within the context of the family and the school. This longitudinal study has expanded over the past few decades into an intergenerational study, retaining the original young men and including their partners and children.

The Oregon Youth Study-Three Generational Study (OYS-3GS) was initiated in 1995 and involves the children born to men who were recruited in 1984-85 (OYS), along with their parents.

The original Oregon Youth Study (OYS) began in 1983. The goal was to examine the etiology of antisocial behaviors in boys, with a view to designing preventive interventions within the context of the family and the school. This longitudinal study has expanded over the past few decades into an intergenerational study, retaining the original young men and including their partners and children.

The Oregon Youth Study-Three Generational Study (OYS-3GS) was initiated in 1995 and involves the children born to men who were recruited in 1984-85 (OYS), along with their parents.

This study is part of the Seek, Test, Treat and Retain (STTR) Collaboration Project that involved over twenty studies in the fields of HIV and drug abuse. All studies were independently developed, but were chosen for the collaboration because they focused on one or more steps of the HIV treatment cascade: Seek, Test, Treat and Retain. As part of STTR Collaboration Project, the studies were grouped into Criminal Justice-related studies and Vulnerable Population-related studies. The data collected by these studies included twelve common domains (e.g., Demographic characteristics, Mental Health) in each of which a shared questionnaire or instrument was taken up by the studies and adapted to fit the study.

These data focuses on individuals that live in Washington D.C. and have at any time been arrested, tested positive for HIV, or have a history with drug use.

The Services Research Outcomes Study (SROS) sought to answer questions about drug treatment efficacy and to describe client characteristics. The study was designed to provide (1) a 1990 cohort of clients to use as baseline for possible changes in treatment outcomes following increased funding to the national treatment system in the 1990s, (2) a before-to-after comparison to measure outcomes of treatment provided in 1990, (3) a follow-up of drug treatment clients five years after treatment to assess the level of sustained improvements in abstinence, and (4) a first look at multiple treatment episodes before and after treatment in a 1990 population.

Part 1 is the Facility Director Interviews and covered topics such as facility staff and organization, revenue and charges, staff hours and compensation, costs, and program characteristics.

Part 2 is the Client Records Abstractions Data, which examined the client records of 2,222 individuals discharged during 1989-1990. Information was abstracted on demographic characteristics of clients, criminal justice involvement, medical conditions, drug history including intravenous drug use, urine test results, drug treatment history, treatment services, and discharge and billing information.

Part 3 consists of the Client Follow-Up Interviews, and was conducted during 1995 and 1996. This part covered the clients' entire life span, with special attention to their behavior and circumstances during the five years before entry to the index (SROS) treatment in 1989-1990 and after leaving that treatment until the time of the interview. Additional questions were asked on patterns of alcohol and drug consumption, criminal activity, employment, health, social support, and other behavior relevant to treatment goals. Drugs included cocaine, crack, heroin, nontreatment methadone, other opiates/synthetics, barbiturates, benzodiazapine, other sedatives/hypnotics, methamphetamines, other amphetamines, marijuana/hash/THC, PCP/LSD, other hallucinogens, inhalants, over-the-counter medications, and alcohol.